sion (1), hypoxia-reoxygenation (2), and remote organ Hypoxia increases the activity of xanthine oxidase (3) injury. The oxidase form is derived from posttrans-(XO) and its precursor, xanthine dehydrogenase lational modification of XDH (4), and accounts for about (XDH), but the mechanism of regulation is unclear. In 10% of the total enzymatic activity (5, 6). However, hypoxic Swiss 3T3 cells, an early (0-24 h) cyclohexi-despite its potential importance in human disease, litmide-insensitive increase in XO-XDH activity, coupled tle is known about the regulation of XO-XDH activity with a lack of increase in de novo XO-XDH synthesis by physiologic stimuli.
emia-reperfusion; inflammation.
ture Collection (ATCC CCL 92), were grown in plastic flasks in MEM with 10% fetal calf serum. Monolayers were uniformly studied on the day of confluence . Human umbilical vein endothelial cells (HU-VEC) were harvested from normal umbilical cords by collagenase XO 2 is an ubiquitous O 2 metabolite-producing en-digestion (11) and grown in 40% Iscove's, 40% RPMI 1640, 20% FBS, endothelial cell growth supplement (100 mg/ml), heparin (50 U/ml), zyme which has been implicated in ischemia-reperfuand antibiotics. Bovine pulmonary artery endothelial cells (BPAEC) were harvested from conduit vessels and grown as previously described (2) . Human 407 embryonic intestinal cells (ATCC CCL 6), 1 To whom correspondence should be addressed. Fax: (303) 315-human HCT-8 ileocecal carcinoma cells (ATCC CCL 244), rat N1-3776. E-mail: lance.terada@uchsc.edu. S1 hepatoma cells (ATCC CRL 1604), mouse Ehrlich-Lettre ascites 2 Abbreviations used: XO, xanthine oxidase; XDH, xanthine dehycarcinoma cells (ATCC CCL 77), and rat Jensen sarcoma cells (ATCC drogenase; HUVEC, human umbilical vein endothelial cells; MEM, CCL 45) were obtained from ATCC and grown in the recommended minimal essential medium; FBS, fetal bovine serum; BPAEC, bovine media. pulmonary artery endothelial cells; PMSF, phenylmethylsulfonyl fluoride; SDS, sodium dodecyl sulfate; HIF-1, hypoxia inducible fac-XO/XDH activity. Cells grown in 75-cm 2 flasks were incubated at 37ЊC in Plexiglas modular chambers flushed with normoxia (21% tor-1; CMV, cytomegalovirus. O 2 , 5% CO 2 ), hypoxia (0% O 2 , 5% CO 2 ), or hyperoxia (95% O 2 , 5% antisense primer which spanned bases 1426-1446 (5-ctgtccaagtcctggaatgag-3) of the mouse XDH open reading frame. These primers CO 2 ) for 24-48 h. Measured O 2 tensions at the end of 48-h incubations were 120 (normoxia), 15 (hypoxia), and 660 (hyperoxia) Torr. amplified a 1286-bp segment from native XDH cDNA and an 888-bp segment from internal standard cDNA. Primers were end-labeled In some flasks, cycloheximide (10 mg/ml) was added prior to exposure. This treatment decreased de novo protein synthesis, as measured by with [g-32 P]ATP using T4 polynucleotide kinase, and PCR amplification (Perkin Elmer 9600) was performed with Taq polymerase (2.5 acid-precipitable 35 S-methionine incorporation, by ú97%. Cells were then triply washed with phosphate-buffered saline and harvested in U) and 30 pmol of each primer in a 50-ml reaction, using 35 cycles of 30 s at 94ЊC, 30 s at 60ЊC, and 90 s at 72ЊC, followed by a 10-2 ml potassium phosphate (50 mM, pH 7.8) with PMSF, dithioerythritol, and EDTA (all 1 mM). Following brief sonication on ice and min extension. The 1286-and 888-bp products were separated by electrophoresis using 1.5% TreviGel 500 (Trevigen, Gaithersburg, centrifugation (400g for 10 min), the supernatant fraction was desalted using 30-kDa cutoff Centricon filters (Amicon, Danvers, MA).
MD), and the respective bands were excised, melted, and counted by liquid scintigraphy (Beckman LS 6500). A plot of log (sample/stanActivity was assessed by incubation of filtered sonicates with or without xanthine, NAD/, or allopurinol, followed by HPLC detection of dard) vs log (number of standard molecules) was used to derive the number of reverse-transcribed sample XDH cDNA molecules. Reacuric acid (2) . Oxonic acid (20 mM) was included in reactions to inhibit uricase. One unit of activity was defined as the formation of one tions lacking RNA or RT did not generate products. In addition, no larger than expected products appeared (the amplified region spans micromole uric acid per minute at pH 7.8, 37ЊC, and was normalized for protein content.
12 introns of the mouse XDH gene (16) This expression vector employs a constitutively driven CMV proAt the end of the exposure, cells were triply washed, harvested in 2 moter. The orientation of several clones was confirmed by restriction ml lysis buffer (15 mM NaCl, 10 mM Na phosphate, pH 7.4, 1 mM mapping, and a sense construct (pGS50) was selected. Transient EDTA, 1 mM PMSF, 10 mM dithioerythritol, 1% Triton X-100, and transfection of 3T3 cells was accomplished in 75-cm 2 flasks with 0.2% SDS), sonicated briefly on ice, and centrifuged at 400g for 10 Lipofectamine (Gibco) using 10 mg/ml transfection lipid, 1 mg/ml of min at 4ЊC. Supernatants were first precleared with irrelevant rabbit either pGS50 or the empty vector pBK-CMV, and 1 mg/ml of a bantisera (10 ml), then rabbit polyclonal anti-XO (10 ml), prepared galactosidase reporter vector (provided by Dr. Robert Tyler). Followas previously described (3), was added and samples were agitated ing a 4-h exposure to lipid/DNA complexes, cells were washed, media overnight at 4ЊC. After agitation for an additional 1 h with 100 ml were replaced, and flasks were incubated under varying oxygen ten-10% Protein A Sepharose (CL-4B, Pharmacia, Piscataway, NJ), the sion in modular chambers for 24 h. The cells were then harvested immunoprecipitates were then washed three times in lysis buffer, and XO-XDH activity was assessed as above and normalized for bseparated by a 7.5% SDS polyacrylamide gel, and fluorographed. galactosidase activity, which was comparable under all oxygen tenAutoradiographs were quantified using a scanning densitometer sions. The effect of oxygen tension on the activity of the CMV pro-(Hoeffer). Preliminary titration experiments demonstrated that Promoter was assessed by assembly of a CMV promoter-driven luciferase tein A sites were not saturated. The antisera consistently immunoconstruct (pCMV-luc). The full-length luciferase insert of pGL2-conprecipitated a 150-kDa protein which was not recognized by irreletrol (Promega, Madison, WI) was removed with HindIII and HpaI vant antisera. Pulse-chase studies were performed by labeling cells digestion, leaving behind the SV40 promoter and enhancer. After gel with 50 mCi 35 S-methionine overnight in methionine-free MEM. Cells purification, the luciferase insert was directionally cloned into the were then triply washed and incubated in methionine-replete media CMV promoter-driven expression vector pcDNA3 (Invitrogen, Carlsunder normoxic, hypoxic, or hyperoxic chambers for 0, 24, 48, or 72 bad, CA) which was previously opened with HindIII and EcoRV. h, then immunoprecipitated and analyzed by fluorography.
Insert orientation of the resultant pCMV-luc construct was confirmed Quantitative RT-PCR. An RT-linked competitive PCR assay was with restriction mapping. 3T3 cells were transiently transfected in developed using an internal PCR standard with primer sequences 75-cm 2 flasks with Lipofectamine, and after a 24-h exposure in differcommon to XDH, as employed for the analysis of a number of genes ent oxygen concentrations, luciferase activity was assessed with a (12-14). The internal standard was prepared from pXDZap 64, which kit (Promega) using a Lumistar luminometer (BMG, Durham, NC). was a kind gift of Dr. Enrico Garattini. pXDZap 64 contains 2 kb of Statistical analysis. Significance was assessed using Analysis of the 5 end of mouse liver XDH cDNA, cloned into the EcoRI site of Variance with Student-Newman-Keuls multiple group testing, and pBluescript SK (15). The internal standard was generated by excissignificance was accepted at P õ 0.05. ing a 398-bp fragment between the two NcoI sites of pXDzap 64 (located at bases 330 and 728 of the mouse liver XDH open reading RESULTS frame), then reclosing the gel-purified plasmid with T4 DNA ligase. Total RNA was extracted from 3T3 cells using RNAzol (Tel-Test, (Table 1 ). In contrast, tions were performed at 37ЊC for 5 min, followed by 42ЊC for 30 min. hypoxia did not alter XO/XDH activity in HCT-8 huReactions were stopped with RNase H, and internal standard (0-man ileocecal carcinoma, N1-S1 rat hepatoma, mouse 1.76 1 10 017 mol) was added to construct a competition calibration
Response of XO-XDH activity to hypoxia is cell-type-
Ehrlich-Lettre carcinoma, or rat Jensen sarcoma cells curve for each sample. PCR was performed using a sense primer which spanned bases 160-179 (5-tgcaccgtgatgatctccaa-3) and an (P ú 0.05). pared to normoxic controls, and the increase in to hypoxia for 24 h did not alter metabolic labeling of XO-XDH (P ú XO/XDH activity was seen despite abrogation of pro-0.05) compared with normoxic cells. However, metabolic labeling of tein synthesis by cycloheximide (Fig. 1) . In contrast, by XO cycloheximide decreased to levels not different (P ú 0.05) from normoxic cells, but higher than normoxic cells treated with cycloheximide (P õ 0.05), whereas (P ú 0.05) in the first 24 h of hypoxic exposure, com-XO/XDH activity of untreated hypoxic cells remained pared with normoxic cells (Fig. 2) , suggesting a compaelevated above normoxic levels (P õ 0.001). In order rable rate of de novo synthesis. However,
35
S-methioto determine the rate of XO-XDH synthesis, metabolic nine labeling of XO-XDH increased during 24-48 h of labeling of XO-XDH with 35 S-methionine over a 24-h hypoxia relative to normoxic cells (P õ 0.05). Pulseperiod, followed by immunoprecipitation, was perchase studies demonstrated that the stability of immuformed. Metabolic labeling of XO-XDH was unchanged noreactive XO-XDH protein was comparable in normoxic (t 1/2 Å 28.3 h), hypoxic (t 1/2 Å 25.8 h), and hyperoxic (t 1/2 Å 23.2 h) environments (Fig. 3) , demonstrating that the differences in metabolic labeling were largely due to differences in rates of synthesis and not degradation.
Effect of hyperoxia on 3T3 XO-XDH activity and immunoreactive protein.
After 24 h, cycloheximide treatment decreased XO-XDH activity (P õ 0.05) in normoxic 3T3 cells (Fig. 4) . However, hyperoxia alone caused a more profound decrease in XO-XDH activity compared with normoxia plus cycloheximide (P õ 0.001), suggesting a more rapid decline in activity due to hyperoxia than could be accounted for by cessation of  FIG. 1 . 3T3 cells grown to confluence were incubated in normoxia de novo protein synthesis. Under normoxic conditions, (21% O 2 ) or hypoxia (0% O 2 ) for 24 or 48 h, in the presence or absence cycloheximide further decreased XO-XDH activity at of cycloheximide (CHX, 10 mg/ml), and XO/XDH activity was mea-48 h, compared to untreated controls (P õ 0.001), to sured. Both cycloheximide-treated and untreated 3T3 cells exposed levels not significantly different from hyperoxic cells.
to hypoxia for 24 h had increased XO/XDH activity (*P õ 0.01) Hyperoxia also decreased metabolic labeling of XOcompared to normoxic controls. Over 48 h, XO/XDH activity of hypoxic cells treated with cycloheximide decreased to levels not different XDH by 35 S-methionine within 24 h (P õ 0.001) and (P ú 0.05) from normoxic cells, but higher than normoxic cells treated from 24 to 48 h (P õ 0.001) (Fig. 5 ). Hyperoxia decreased metabolic labeling of XO-XDH from 0 to 24 h (*P õ 0.001) and from 24 to 48 h (*P õ 0.001), compared to normoxia. Values are the mean { SE of four to nine individual determinations.
cells exposed to 24 h of normoxia, hyperoxia, or hypoxia ( Fig. 6 , P ú 0.05). However, 48 h exposure to hypoxia both hypoxia and hyperoxia appeared to impart postincreased XDH mRNA levels compared to normoxic or translational effects on XO-XDH within 24 h, cells were hyperoxic exposure (P õ 0.01). XDH mRNA levels in hypharvested after 24 h of exposure. Oxygen tension aferoxic cells were not significantly different from those in fected neither transfection efficiency, as assessed by bnormoxic cells at 48 h (P ú 0.05).
galactosidase activity, nor activity of the CMV proEffect of oxygen tension on XO-XDH activity of transfected 3T3 cells. The effect of oxygen on the posttranscriptional regulation of XO-XDH activity was further assessed by transfection of 3T3 cells with a constitutively driven D. melanogaster XDH construct. Since   FIG. 6 . 3T3 cells were exposed to 24 or 48 h of normoxia, hyperoxia, or hypoxia, and total RNA was reverse transcribed and subjected to competitive PCR, using a truncated mouse XDH cDNA. End- labeled  FIG. 4 . 3T3 cells were incubated in normoxia or hyperoxia (95% O 2 ) for 24 or 48 h, in the presence or absence of cycloheximide (CHX, primers were used and bands were excised and counted. XO-XDH mRNA levels were not different in 3T3 cells exposed to 24 h of nor-10 mg/ml), and XO/XDH activity was measured. At 24 h, cycloheximide treatment decreased XO-XDH activity (*P õ 0.05) in normoxic moxia, hyperoxia, or hypoxia (P ú 0.05). Cells exposed to 48 h hypoxia had increased XO-XDH mRNA levels compared to cells exposed 3T3 cells. Hyperoxia decreased XO-XDH activity compared with normoxia plus cycloheximide (**P õ 0.001). Cycloheximide further de-to normoxia or hyperoxia (*P õ 0.01). XO-XDH mRNA levels in hyperoxic cells were not different from those in normoxic cells at 48 creased XO-XDH activity at 48 h compared with normoxic controls ( # P õ 0.001), to levels not significantly different from hyperoxic cells. h (P ú 0.05). Values are the mean { SE of four to six individual determinations. Values are the mean { SE of four to eight individual determinations.
an early posttranslational effect, 3T3 cells transfected with D. melanogaster XDH, whose expression was driven by a constitutive, oxygen-insensitive promoter, displayed an accentuated increase in XO-XDH activity in hypoxia compared to normoxia. Conversely, under hyperoxic conditions, XO/XDH activity declined much faster than would be expected if de novo synthesis were simply shut off, suggesting a posttranslational inactivation of XO-XDH. Indeed, treatment of cells with cycloheximide decreased activity at a rate more consistent with the half-life of immunoreactive XO-XDH protein. As further evidence for hyperoxic inactivation, transfection of 3T3 cells with XDH did not restore activity under hyperoxic conditions.
Although the mechanism of this posttranslational ef- fect is not clear, there is precedence for such modificamelanogaster XDH cloned downstream from the CMV promoter. Transfected cells were exposed to 24 h of normoxia, hypoxia, or hytion of XO-XDH activity. For instance, both oxygenperoxia, and XO/XDH activity was assessed. In normoxia, transand nitrogen-centered radicals have been found to inacfected cells had increased XO/XDH activity compared to control cells tivate the enzyme (9, (18) (19) (20) , and desulfuration of the (*P õ 0.05). Hypoxia exaggerated the increase in activity due to molybdenum active site also renders XO-XDH inactive.
transfection roughly threefold (**P õ 0.001). Whether mammalian XDH undergoes regulated resulhigher XO/XDH activity than nontransfected cells unfuration in vivo is not known, although it is interesting der both normoxic (P õ 0.05) and hypoxic (P õ 0.001) conditions (Fig. 7) . However, transfection increased to note that large quantities of inactive desulfo XO-XO/XDH activity in hypoxic cells by a larger margin XDH have been found in human milk (23) and possibly than in normoxic cells, despite the lack of effect of hyp-heart (24) . oxia on CMV promoter activity. Similarly, transfection
We also found evidence for pretranslational control of 3T3 cells with pGS50 did not increase XO/XDH of de novo XO-XDH synthesis by oxygen tension. For activity in hyperoxic cells compared to nontransfected instance, in the later 24-to 48-h period of hypoxia, hyperoxic cells (P ú 0.05) despite the lack of effect of both mRNA transcript levels and the rate of metabolic hyperoxia on CMV promoter activity.
labeling of XO-XDH increased. In parallel, cycloheximide treatment abrogated the hypoxic increase in XO-
DISCUSSION
XDH activity during this time period. Conversely, in hyperoxia, de novo XO-XDH protein synthesis ap-A substantial body of data implicates XO-XDH in peared to decrease. In support of this conclusion, metainflammatory and ischemic diseases of humans and bolic labeling of XO-XDH decreased within 24 h of hyother animals, emphasizing the importance of this enperoxia despite little change in the protein's half-life. zyme's regulatory mechanisms. We had previously Although we did not find a significant difference in found that hypoxia increases whereas hyperoxia de-XO-XDH mRNA levels, a nonsignificant decrease was creases XO-XDH activity (2, 9) , and now find evidence noted after 48 h of hyperoxia. for oxygen regulation of XO-XDH at both pre-and postInterestingly, one group found similar evidence for translational levels.
alterations in XO-XDH gene expression by oxygen tenHypoxia altered XO-XDH activity in 3T3 cells inision (7, 12) , while another group found no alterations tially through posttranslational means. In the first 24 in XO-XDH transcript levels (8) . The reason for this h of hypoxic exposure, we found a cycloheximide-insendiscrepancy is not clear, although a cell-specific differsitive increase in XO-XDH activity. In parallel, metaence in XO-XDH expression may exist, as has been bolic labeling of XO-XDH did not increase, suggesting noted for cytokine induction of the enzyme. For inthat the rate of XO-XDH synthesis did not change in stance, interferon a increases XO-XDH transcription the first 24 h of hypoxia. Consistent with this, XO-XDH mRNA levels did not increase. In further support of in L929 and 3T3 cells (25) but not rat lung endothelial
